Of the 6141 total patients treated with IGF-1/R inhibitors, 2825 received monotherapy, 3315 received combination therapy, 5951 were treated for cancer, 161 were treated for TED, and 28 were healthy. This evidence concerns the gene IGF1 and cancer.